Provider Policy Notifications
This page contains notifications for clinical policies that have future effective dates. For current policies, visit the Clinical Policies page.
Policies effective 11/1/2025
- Allogeneic Hematopoietic Progenitor Cell Therapy (PDF) (CP.MP.249)
- Fecal Incontinence Treatments (PDF) (CP.MP.137)
- Reduction Mammoplasty and Gynecomastia Surgery (PDF) (CP.MP.51)
- Total Artificial Heart (PDF) (CP.MP.127)
Policies effective 12/1/2025
- Physical, Occupational and Speech Therapy Services (PDF) (CP.MP.49)
- Skin and Soft Tissue Substitutes for Chronic Wounds (PDF) (CP.MP.185)
Policies effective 1/1/2026
- Bone-anchored hearing aid (PDF) (CP.MP.93)
Policies effective 11/1/2025
- Allogeneic Hematopoietic Progenitor Cell Therapy (PDF) (CP.MP.249)
- Fecal Incontinence Treatments (PDF) (CP.MP.137)
- Reduction Mammoplasty and Gynecomastia Surgery (PDF) (CP.MP.51)
- Total Artificial Heart (PDF) (CP.MP.127)
Policies effective 12/1/2025
- Hospice Services (PDF) (WA.CP.MP.54)
- Physical, Occupational and Speech Therapy Services (PDF) (CP.MP.49)
- Skin and Soft Tissue Substitutes (PDF) (WA.CP.MP.185)
Policies effective 1/1/2026
- Bone-anchored hearing aid (PDF) (CP.MP.93)